Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure

Michael E. Ray, Larry B. Levy, Eric M. Horwitz, Patrick A. Kupelian, Alvaro A. Martinez, Jeff M. Michalski, Thomas M. Pisansky, Michael J. Zelefsky, Anthony L. Zietman, Deborah A. Kuban

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure'. Together they form a unique fingerprint.

Medicine & Life Sciences